Central Licensing Authority Archives - CliniExperts -CliniExperts

Central Licensing Authority

What's New 2?

Regulation/Guidelines

Guidelines for Prevention of Consumers from Misleading Advertisements and Endorsements for Misleading Advertisements, 2022

India's central consumer protection body published rules for preventing misleading commercials and endorsements for misleading advertisements 2022 on June 9th, 2020. CCPA announced the Guidelines to fulfill the duties given...

5th August, 2022

Regulation/Guidelines

Draft of the new bill on New Drugs, Medical Devices and Cosmetics, 2022

The new draft bill consists of a few new definitions such as clinical trials, over-the-counter drugs, manufacturers, cosmetics, medical devices, new drugs, bioavailability, investigational new drugs, imported spurious drugs, predicate...

28th July, 2022

Regulation/Guidelines

CLASS B MEDICAL DEVICE/IVD MANUFACTURING AND PRODUCT DEVELOPMENT SUPPORT

Class B Medical Devices / In-Vitro Diagnostic Kits Class B medical devices have low to moderate risk to the patients and public health risks. Class B medical devices’ permissions or...

21st July, 2022

Regulation/Guidelines

Manufacturing And Product Development Support for Medical Devices / IVDs (Class C & Class D)

Manufacturing And Product Development Support for Medical Devices / In-Vitro Diagnostic Kit The medical device industry of India is a crucial and integral part of the Indian healthcare industry. It...

7th July, 2022

Our Office Address

CliniExperts Services Pvt. Ltd.

Delhi Office
Unit No. 325, City Centre Mall, Plot No. 5, Sector 12, Dwarka, New Delhi – 110075

Bengaluru Office
RMZ Galleria, 1st floor, Ambedkar Colony, Yelahanka, Bengaluru, Karnataka – 560064

Central Licensing Authority

Central Licensing Authority

New Rules for Clinical Trials and Drugs Promote Research and Ensure Patient Safety

Draft of New Regulations for Clinical Trials in India Favours Drug Development in the Country

Our Office Address